Voloridge Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-8,088
| Closed | -$485K | – | 1328 |
|
2023
Q3 | $485K | Sell |
8,088
-8,123
| -50% | -$487K | ﹤0.01% | 1215 |
|
2023
Q2 | $1.17M | Sell |
16,211
-8,045
| -33% | -$580K | 0.01% | 1093 |
|
2023
Q1 | $1.78M | Buy |
24,256
+11,628
| +92% | +$855K | 0.01% | 1004 |
|
2022
Q4 | $844K | Buy |
+12,628
| New | +$844K | ﹤0.01% | 1170 |
|
2021
Q4 | – | Sell |
-18,834
| Closed | -$1.64M | – | 1718 |
|
2021
Q3 | $1.64M | Sell |
18,834
-66,933
| -78% | -$5.82M | 0.01% | 1119 |
|
2021
Q2 | $7.02M | Sell |
85,767
-47,410
| -36% | -$3.88M | 0.05% | 521 |
|
2021
Q1 | $12.7M | Buy |
133,177
+94,888
| +248% | +$9.02M | 0.09% | 288 |
|
2020
Q4 | $2.38M | Buy |
38,289
+23,437
| +158% | +$1.45M | 0.02% | 670 |
|
2020
Q3 | $883K | Sell |
14,852
-18,976
| -56% | -$1.13M | 0.01% | 974 |
|
2020
Q2 | $2.36M | Sell |
33,828
-32,369
| -49% | -$2.26M | 0.03% | 566 |
|
2020
Q1 | $3M | Buy |
66,197
+30,992
| +88% | +$1.41M | 0.09% | 255 |
|
2019
Q4 | $2.29M | Sell |
35,205
-20,722
| -37% | -$1.35M | 0.04% | 457 |
|
2019
Q3 | $3.47M | Buy |
55,927
+11,873
| +27% | +$737K | 0.06% | 326 |
|
2019
Q2 | $3.14M | Buy |
44,054
+10,806
| +33% | +$769K | 0.09% | 247 |
|
2019
Q1 | $2.61M | Sell |
33,248
-31,879
| -49% | -$2.5M | 0.08% | 248 |
|
2018
Q4 | $5.51M | Buy |
+65,127
| New | +$5.51M | 0.25% | 108 |
|
2018
Q3 | – | Sell |
-62,604
| Closed | -$8.09M | – | 394 |
|
2018
Q2 | $8.09M | Buy |
62,604
+5,957
| +11% | +$770K | 0.22% | 110 |
|
2018
Q1 | $5.84M | Buy |
+56,647
| New | +$5.84M | 0.14% | 135 |
|
2017
Q4 | – | Sell |
-26,918
| Closed | -$2.29M | – | 550 |
|
2017
Q3 | $2.29M | Buy |
+26,918
| New | +$2.29M | 0.05% | 262 |
|
2016
Q3 | – | Sell |
-71,723
| Closed | -$5.34M | – | 289 |
|
2016
Q2 | $5.34M | Buy |
+71,723
| New | +$5.34M | 0.15% | 134 |
|